EFFECTIVENESS OF NEOADJUVANT CHEMOTHERAPY IN PATIENTS WITH BREAST CANCER

Zenodo (CERN European Organization for Nuclear Research) 2026 Open access

Read full text
Authors: Сугдиана Хайдаралиева
DOI: 10.5281/zenodo.18858890
Cited by: 0

Abstract

Neoadjuvant chemotherapy (NACT) for breast cancer (BC) is highly effective in reducing tumor size, converting unresectable tumors to operable ones, and increasing the rate of breast-conserving surgery. Achieving a complete pathological response (pCR/RCB-0) significantly improves 5-year relapse-free survival (up to 92-94%), especially in HER2-positive and triple-negative breast cancer.

Fields of Study & Subjects

Breast Cancer Treatment Studies Breast Lesions and Carcinomas MRI in cancer diagnosis

Publication details

Journal / source
Zenodo (CERN European Organization for Nuclear Research)
Publication date
4 March 2026
Language
EN